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DECREASING COST ASSOCIATED MEDICATION NONADHERENCE

An Abstract of the Scholarly Project by
Shawn E. Raymond

Medication cost is a major contributor for patient medication nonadherence. Take
in the fact that a large population lives in poverty, many cannot afford to pay the retail
prices associated with purchasing their medications. By incorporating wholesale
medications into a charitable health clinic, the reduced cost of medications for treatment
of both acute and chronic illnesses could be passed on to those in need thereby decreasing
cost associated medication nonadherence. Nurse Practitioners in the state of Kansas are
not afforded the privilege to purchase, repackage and distribute or resell wholesale
medications like their physician counterparts. If current legislation were changed to allow
this to happen, even if it is only in the setting of the charitable healthcare clinics, those
individuals who are uninsured and in poverty would have more affordable access to
prescription medications. By increasing the affordability of the medications and
decreasing cost associated medication nonadherence, the health status of this population
could be greatly improved.
Keywords: wholesale medications, retail medications, medication nonadherence,
medication adherence, medication compliance, medication noncompliance, advanced
practice nurse, nurse practitioner, charity, charitable health, rural health, cost associated
noncompliance, cost associated nonadherence, medication cost, poverty.
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CHAPTER I

INTRODUCTION

Description of the Clinical Problem
Medication costs have always been a barrier to patient medication adherence in
the treatment of acute and chronic illnesses throughout the United States and around the
World. “Prescription medication costs increase financial burden, often leading
individuals to engage in intentional nonadherence” (Martin, Shreffler, Schoster, &
Callahan, 2012, p. 236). Medication nonadherence leads to worsening of both acute and
chronic illnesses, and at the same time increases the overall cost of treating those
illnesses by requiring additional diagnostics, treatments and even hospitalizations. It has
been estimated that approximately 125,000 deaths in the United States each year can be
attributed to medication nonadherence (Bosworth et al., 2012, p. 2). The total cost
estimates for nonadherence range from $100-$300 billion each year, and include both
direct and indirect costs (Bosworth et al., 2012, p. 2). When taken into account that 1.2
billion people around the world live in extreme poverty, this problem is greatly
compounded (Theis, 2013). To show how prevalent the topic is within scholarly
literature, Goldberg, DeKoven, Schabert, and Coyle (2009) performed a review of the
literature that spanned 40 years, 1967-2007, to show the magnitude in which medication
1

nonadherence was written about. Results of that review are illustrated in Figure 1 (see
Appendix A). In 1977, approximately 300 articles were written on medication adherence
that year alone; 30 years later in 2007, there were approximately 4,500 articles written
within that same one-year timespan.
Significance
Many individuals often attempt to extend their medication prescriptions by
purposefully skipping doses, and in worst case scenarios do not get them filled because
they cannot afford them. By showing a definite link between cost of medications and
medication adherence by patients, this project will demonstrate that allowing medications
to be sold at wholesale cost will increase medication adherence. Medication
nonadherence, related to cost, can effectively be decreased by utilizing wholesale
medication throughout the United States. Also, by reducing the costs of those
medications necessary to treat both acute and chronic illnesses, patients will keep more of
the money they earn, effectively helping to increase their financial stability and quality of
life.
Purpose
The purpose of this project is to propose a legislative change that will allow Nurse
Practitioners (NPs) to incorporate wholesale medications into a NP operated Charitable
Health Clinic (CHC) in rural southeast Kansas. By doing this, data can be collected to see
if offering medications at wholesale cost will increase medication adherence, based on
the reduced cost associated with the purchasing the medications needed for treating the
individual’s acute or chronic illness. According to Iuga and McGuire (2014), “Reducing
2

out-of-pocket costs leads to better medication adherence across many diagnoses. There is
a linear relationship between the magnitude of patient cost sharing and the level of
adherence.” At times, statements are voiced from individuals that directly correlate to the
cost associated with the treatment option/s chosen by the provider; statements like “I
can’t afford that.” or “we’ll have to wait until payday.” The CHC that will be referenced
in this project is run by donations only; there is no cost associated with being seen by the
provider. By eliminating the cost associated with being seen by a provider, the hope is
that the individuals will be able to afford the medications, at the wholesale price, thus
increasing medication adherence for acute and chronic illnesses by those individuals
using the CHC.
In the state of Kansas, NPs are required to have a Collaborative Practice
Agreement with a Physician to practice. Physicians within the state of Kansas that offer
wholesale medications in their clinics are able to buy these medications in bulk,
repackage the medications, and resell the medications to their patients; NPs cannot. It is
yet to be determined what process it will take to incorporate wholesale medications into
the CHC at the time of this writingt. This project will be utilized to petition the Kansas
state legislators, to seek change within the state giving NPs equal privileges as physicians
to purchase, repackage and dispense or resell wholesale medications.
To start, a comparison was made to determine what the cost difference was
between wholesale and retail medications. An online medication wholesaler,
Andameds.com, was used to collect wholesale prices of a few common medications in
the treatment of both acute and chronic illness. These wholesale prices were then
3

compared to the retail prices for the same medications using GoodRX.com. By
comparing the prices of these medications, it was apparent the cost savings that could be
passed on to the patients was fairly significant. Table 1 (see Appendix A) lists the
medications with breakdown of cost per pill, as well as cost for a standard course of
treatment, whether it is a 5-day, 10-day or 30-day course. Prices were taken from each
website and compiled into Table 1 on September 15, 2015.
Theoretical Framework/Conceptual Analysis
The theoretical framework used for this specific work is based on the Health
Belief Model (HBM). The HBM was originally written in the 1950s by a group of
psychologists at the United States Public Health Services (Janz & Becker, 1984). The
HBM was utilized as “a conceptual formulation for understanding why individuals did or
did not engage in a wide variety of health related actions, and provided considerable
support for the model” (Janz & Becker, 1984, p. 1). Initially, the HBM was written in an
attempt to understand why people did not undergo preventative care for the early
detection of “asymptomatic disease” (Janz & Becker, 1984, p. 2). The HBM later went on
to incorporate aspects of how people responded to symptoms of the disease process, as
well as medication adherence.
The HBM first addressed Perceived Susceptibility which constitutes an
individual’s perception of the risk to contract a disease or illness. Second, the HBM
addressed Perceived Severity of the illness if contracted, as well as the physical,
emotional, and economic costs of leaving the condition untreated. Next, Perceived
Benefits were addressed. This established if there were any benefits to leaving the
4

condition untreated or obtaining treatment. Finally, Perceived Barriers, defined as
anything that hindered the individual from obtaining treatment for the condition, were
addressed.
Due to the fact that the CHC sees those patients who are uninsured or
underinsured, the total cost associated with the treatment of the acute and chronic
illnesses plays a large part in nonadherence. Many patients are denied services when they
do not have the monetary means or insurance coverage to pay for the testing or
medications up front. By addressing the HBM factors that hinder individuals from getting
the diagnostics and treatments they need, this project hopes to show an increase in the
health and wellness of this population.
Project Objective
The objective of this project was to petition area senators and legislators to
change the current legislation in the state restricting Advanced Practice Nurses (APNs) to
purchase, repackage and dispense or resell wholesale medications to the
uninsured/underinsured individuals that are cared for at NP run CHCs within the State of
Kansas.
Definition of Key Terms
adherence
“The WHO defines adherence as ‘the extent to which the persons' behavior
(including medication-taking) corresponds with agreed recommendations from a
healthcare provider’” (Lam & Fresco, 2015, p. 1).
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charitable
1. “Generous in giving money or other help to the needy.”
2. “Mild or tolerant in judging others; lenient.”
3. “Of, for, or concerned with charity: a charitable organization”
(“Charitable,” 2009).
clinic
“A facility, often associated with a hospital or medical school that is devoted to
the diagnosis and care of outpatients” (“Clinic,” 2003).
compliance
“The extent to which the patients' behavior (including medication-taking)
coincides with medical or healthcare advice” (Lam and Fresco, 2015, p. 1).
healthcare
“The prevention, treatment, and management of illness and the preservation of
mental and physical well-being through the services offered by the medical and
allied health professions” (“Healthcare,” 2003).
medication adherence
“The extent to which patients take medication as prescribed by their health care
providers”; “the patient’s conformance with the provider’s recommendation with
respect to timing, dosage, and frequency of medication taking during the
prescribed length of time” (Viswanathan et al., 2012, p. 1).
nurse practitioner
“[Registered] nurses who are prepared, through advanced education and clinical
training, to provide a wide range of preventive and acute health care services to
6

individuals of all ages” (O'Grady, 2008, p. 605). Nurse Practitioners “take health
histories and provide complete physical examinations; diagnose and treat many
common acute and chronic problems; interpret laboratory results and x-rays;
prescribe and manage medications and other therapies; provide health teaching and
supportive counseling, with an emphasis on prevention of illness and health
maintenance; and refer patients to other health professionals as needed” (O'Grady,

2008, p. 605).
Abbreviations
Advance Practice Nurse/s

APN/APNs

Charitable Health Clinic

CHC

Chronic Care Model

CCM

Centers for Medicare and Medicaid Services

CMS

Doctor of Nursing Practice

DNP

Health Belief Model

HBM

Kansas State Board of Pharmacy

KSBP

Kansas State Board of Nursing

KSBN

Medicare Part D

MPD

Medication Therapy Management

MTM

Nurse Practitioner/s

NP/NPs

Out of Pocket

OOP

Socioeconomic Status

SES

Southeast Kansas

SEK

Verdigris Valley Charitable Health Clinic
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VVCHC

World Health Organization

WHO

Logic Model
The Verdigris Valley Charitable Health Clinic (VVCHC) Logic Model was
specifically created for this project. This logic model breaks down factors that were and
will need to be addressed prior to initiating, and throughout this evolving project. The
logic model is broken down into three separate sections: inputs, outputs and outcomesimpacts. The input section compiles a list of primary issues that face this project overall.
Without all of these aspects falling into place, this project will not succeed. The outputs
section details what each input’s activities and participation level will be within this
project. The outcomes-impact section lays out short-, medium- and long-term goals that
will need to be achieved for completing and continuing of this project. An example of the
logic model would be the following:
Inputs:

Pittsburg State University’s Irene Ransom School of Nursing

Outputs:

Activities: Approval and oversight of the DNP Scholarly Project
Participation: Guidance and oversight of the project, peer review
project to ensure compliance with evidence based research.

Outcomes:

Short: Project was approved by the DNP advisor and committee.
Medium: Project was validated through peer review.
Long: Scholarly Project was defended successfully.

The complete VVCHC Logic Model can be found in Table 2 (see Appendix A).
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Chapter Summary
Cost is a significant factor in medication nonadherence and it leads to worsening
of both acute and chronic illnesses. With medication adherence comes a substantial
increase in the costs associated with the treatment of worsening illness, both direct and
indirect. Cost estimates range from $100-300 billion each year (Bosworth et al., 2012). A
review of the literature by Goldberg, DeKoven, Schabert, and Coyle (2009) shows the
vast increase in articles written on the subject matter over the years with approximately
4,500 articles published in 2007 alone (Figure 1, see Appendix A).
The purpose of this project was to not only incorporate wholesale medications
into a NP operated CHC in rural southeast Kansas, and to legislate for policy changes
through the state government to give NPs the same privileges that physicians have when
it comes to buying, repackaging and dispensing or reselling wholesale medications. By
offering medications at wholesale cost this project will determine if there is an increase
medication adherence, based on the reduced costs associated with purchasing the
medications needed to treat an individual’s acute or chronic illness.
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CHAPTER II

REVIEW OF THE LITERATURE

Introduction
The review of literature will help support the pretense of this project, that cost is a
factor to medication adherence. This chapter focuses on the various populations that are
affected from the cost of purchasing retail medications, as well as the laws that keep
APNs from purchasing, repackaging and dispensing/reselling wholesale medications. The
information highlighted in this section was used to educate the legislative representatives
on not only the problem that cost association has on medication adherence, but a solution
to the problem at hand.
To validate that the costs associated with medication is a factor in adherence, a
meta-analysis of the published literature was conducted. The literature was reviewed for
validity of subject matter, currency of information, and publication type. Only the work
that was published in scholarly, peer reviewed sources within the last five years was
included. The information was gathered in a range of various settings, but all information
did reveal that, among other variables, cost was a determining factor in medication
adherence in the treatment of acute and chronic illnesses.
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Literature was gathered from multiple resources using various search criteria.
Various online databases were utilized within this review of literature to include
CINAHL Plus with Full Text, PubMed, PubMed Central, PubMed Clinical Queries and
Proquest Nursing & Allied Health Source; another online resources utilized was Google
Scholar. Search sting queries consisted of multiple combinations of the following;
medication adherence, medication compliance, cost, costs, afford, affordability, reduced
adherence, reduced compliance, wholesale, wholesale medications, charity, charitable,
charitable health, charitable health clinic, retail pharmacy, wholesale pharmacy,
socioeconomic status, poverty, poor, working poor, uninsured, underinsured, fixed
income. Initially very few articles met the criteria for this study, but after extensive
research the following literature was chosen to conduct this review.
Medication Adherence
Medication adherence is key to increasing the health status of those who
experience acute and chronic illnesses. According to Mackey et al., (2015), the World
Health Organization reported medication adherence for those with chronic illnesses only
averaged 50% in developed countries (p.2). An estimated 50-60% of those with chronic
conditions are noncompliant with medication treatment regimens (Bosworth et al., 2011,
p. 2). Medication nonadherence overall drastically reduces the optimal health and
wellness of an individual, and also increases the overall costs of individual treatment,
possibly requiring more office visits or hospitalizations due to their poor health state.
Approximately 1.6 billion prescriptions filled within the Unites States each year are not
taken as prescribed (Bosworth et al., 2011, p. 2).
11

Socioeconomic factors that play into nonadherence include socioeconomic status
(SES), whether patients are insured, underinsured, or uninsured, availability to medical
care; and availability to pharmaceuticals. Mackey et al (2015, p. 2), found that “patient
characteristics such as age, sex, race, and education are associated with medication
adherence,” as well as “financial burdens such as low income or socioeconomic status,
lack of prescription drug coverage, and high out-of-pocket costs”. In addition, WHO
divides the circumstances that lead to nonadherence “into five categories: socioeconomic
factors, therapy-related factors, patients-related factors, condition-related factors, and
health system/ health care team (HCT) related factors” (Lam & Fresco, 2015, p. 2).
Therapy-related factors include various medication reactions such as rash, nausea,
vomiting and anaphylaxis. Other therapy-related factors include inability to purchase
medications, unavailability of medications or even in rural areas inability to get to where
the therapy-related items are sold. Patient-related factors include refusing to take
medication or not having the medication available at the time it is to be administered.
Condition-related factors include inability to take the medication as prescribed due to
disease process or medical condition, inability to take medication due to cognitive
function, inability to take the medication due to decreased recall of current treatment
plan, and inability to take medications due to pain, blindness, weakness, loss of function
of upper extremities, nausea or vomiting. Health care team (HCT) related factors consist
of issues such as medical professionals forgetting to inform the patient of changes to the
medication plan, forgetting to call new medication in, or forgetting to tell the patient that
they had called something in. Other examples could include the provider not taking into
12

account the individual’s SES or insurance information when calling or faxing in a new
medication that the individual cannot afford and ineffective communications between the
HCT and the individual.
For over 40 years, researchers have used various methods to determine adherence,
but none have ever been considered the gold standard (Lam & Fresco, 2015, p. 2).
Therefore, multiple techniques must be utilized in studies to enhance the effectiveness of
the gathered data. Without testing multiple techniques to measure adherence, researchers
could possibly misrepresent the data and show more or less adherence than there actually
is. This error in data representation could cause harmful and unnecessary consequences at
all levels of the healthcare delivery system.
Uninsured/underinsured. Out of the hundreds of sources reviewed, the article
that most specifically related to this project was Alton, March, Mallary, and Fiandt’s
(2015) “Medication Adherence in a Nurse Practitioner Managed Clinic for Indigent
Patients.” As the authors themselves state, “Little is published in the literature about
medication adherence rates among patients who are medically indigent and patients
receiving primary care from nurse practitioners (NPs)” (Alton et al., 2015, p. 433). This
study was a cross-sectional analysis that looked at adherence and barriers to treatment
plans in the indigent population that were specifically cared for in a NP run health clinic
and were deemed to be uninsured or low income. Participants were surveyed on
adherence issues and barriers to treatment with “surveys eliciting demographic
information, self-report of medication adherence, health literacy, and barriers to
adherence” (Alton et al., 2015, p. 433). An unusually large return rate 77% was noted in
13

this study. Two definitive causes of this return were most frequently identified, and one
of those was inability to afford medications (62.5%). The other involved Hispanic
patients’ inability to understand medication labels. The takeaway point of this project was
the need to improve patient access to affordable medications, which could in effect
increase rates of medication adherence within that particular clinic and patient
population.
A qualitative study published in the journal Health & Social Work in 2011
explored various aspects of adherence and nonadherence in low-income individuals with
multiple comorbid disease processes. The study accounted for both the physical and
mental aspects of chronic illness (Mishra, Giola, Childress, Barnet, & Webster, 2011).
They found that various factors played into the adherence level, or lack thereof, of
medication treatment plans. Some of those factors that affected medication treatment
plans included “medication side effects, fear of harm from medication, fear of
dependence on medication, complex instructions, suboptimal communications with
doctor, suspicion about doctors’ and pharmaceutical companies’ motives in prescribing
medication, and the high cost of medications” (Mishra et al., 2011, p. 249). Also
identified were various motivators for medication adherence that actually increased
medication adherence in that study; these were “faith, support from family members and
doctors, and focused health education and self-management support” (Mishra et al., 2011,
p. 249). During the study Mishra et al. also noted financial status as being a large
contributor to nonadherence as well; the medications were too expensive and just
increased patients’ financial strain. One participant in this study stated, “I was working
14

and I got laid off and I had to pay for my medications and it cost me $97 to get all of my
prescriptions and I don’t have $97, so I had to choose what medication was the most
important” (Mishra et al., 2011, p. 252). This, many times, is what individuals on fixed
incomes or low incomes face when they have chronic illnesses. Individuals with acute
and chronic illnesses can have every intention of being adherent with their primary
provider’s medication treatment plans but if they cannot afford the medications there is
no way they can be adherent.
Chronically ill/elderly. Medication nonadherence, due to cost can be
increasingly influenced by the number of medications an individual is on. This state of
taking multiple medications is called polypharmacy. Older adults have vastly unique and
challenging barriers, that may not be shared by other age groups. According to Marcum
and Gellad (2012), barriers for older adults could include “managing multi-drug
regimens, cognitive impairment, functional limitations, financial restraints, use of
multiple health care providers, [and/] or transportation limitations” (p. 1). The more
chronic illnesses an individual has, the more medications it will take to control the
progression of those chronic conditions.
There are multiple stages in which an elderly or chronically ill individual could be
nonadherent; these include getting the prescription filled when new medications are
prescribed, starting to take the medications as prescribed, continuing to take the
medication as prescribed (in those who suffer from chronic conditions), and taking the
medication for its intended purpose (Marcum & Gellad, 2012). Multiple studies have
been conducted with regard to nonadherence in the elderly; these studies have shown that
15

approximately 50% of the elderly population are nonadherent on at least one of their
medications, whether intentionally or unintentionally (Marcum & Gellad, 2012). Marcum
and Gellad (2012) identified three different types of medication nonadherence,
nonfulfillment, nonpersistence, and nonconforming (p. 1). Primary nonadherence
revolves around not picking up the medication that was prescribed to the individual,
nonpersistence is stopping a medication prior to taking the full course of the prescribed
medication, and nonconforming relates to not taking the medication as prescribed,
whether it is taking doses at the wrong time or skipping doses altogether (Marcum &
Gellad, 2012). There are various reasons individuals may be noncompliant, but per
Marcum and Gellad (2012). “The most common health-system barrier to medication
adherence is cost. Cost is clearly more of a problem for those patients taking more
medications, and thus polypharmacy may affect adherence through higher cost-sharing”
(p. 4).
Mackey et al. (2012) performed a study using the Chronic Care Model (CCM) to
see if this model of treatment would increase medication adherence compared to those
who were not treated under this model. They sent out surveys to 40 small community
healthcare clinics. Participants in this study were 18 years or older and had at least one
chronic illness (mean 2.4). The surveys were based on the Morisky Medication
Adherence Scale, the Patient Assessment of Chronic Illness Care, and a set of frequently
used items developed by Piette and colleagues (Piette, Heisler, & Wagner, 2004) that
helps assess cost-related burdens. A total of 2,634 surveys were given out with 2,392
returned for an astonishing, 90.8% completion rate. Statistical analysis was performed on
16

the collected data and showed “prescription costs and perceptions of care experiences
were significantly associated with medication adherence” and a “high prevalence of poor
adherence among chronically ill individuals” (Mackey et al., 2012, p. 5). With regard to
the CCM, patients that were treated under this model did show improvement with
medication adherence, compared to those who were not treated under it.
Medicare supplemental population. Members of the Medicare supplemental
population face unique challenges regarding nonadherence. Mixon, Neal, Bell, Powers,
and Kripalani (2015) stated that “Older adults typically take more medications than
younger adults due to multimorbidity associated with advanced age” (p. 1). Musich et al.
(2015) found that those individuals who were on a Medicare supplemental insurance plan
took approximately seven different prescription medications each year, “resulting in
substantial out-of-pocket drug copayments, in addition to Medicare Supplement and
Medicare Part D (MPD) premiums” (p. 1208). Seniors on Medicare who may have
supplemental coverages also fall into the area of being able to not afford certain
prescriptions based on cost or many have multiple medications so the cost increases for
the amount of medications they may be on. Because many older Americans are on a fixed
income and are at or below the poverty line medication costs can tax an already limited
budget, based from many older adults being on a fixed income. Per Musich et al. (2015)
out of pocket spending (OOP) rates were very sensitive to the rate of medication
nonadherence, “OOP spending increases with higher numbers of medications, medication
nonadherence increases” (p. 1209). As for Mixon et al. (2015), “before the
implementation of MPD (prescription drug insurance) in the USA, 2 million older adults
17

were nonadherent to their drug regimen due to lack of prescription coverage” (p. 5). Even
though MPD came about to give these millions of older adults’ medication coverage,
there is still what is known as the donut hole in which the person reverts back to paying
full price for medications. The donut hole starts when a person reaches the annual
spending limit set by Medicare. Based on the amount of chronic illness and the amount
and cost of medications the individual is on, the individual may hit that donut hole
midway through the fiscal year while others may hit towards the end of the year. Mixon
et al. (2015) showed in their article that the ‘donut hole’ increased medication
nonadherence in the Medicare population “with fewer prescriptions filled and more gaps
in therapy” (p. 5). The donut hole is currently in the process of phasing out, but this will
not take place for another four years (2020). Until that time though, many poor, older
adults will continue to hit the donut hole and have to make the decision whether to
purchase their medications or purchase food and pay their utilities.
In 2013 a study was done by Carr-Lopez et al. during the MPD open enrollment
period. Medication Therapy Management (MTM) teams were dispatched to six different
central and northern California cities. Student pharmacists under direct supervision
provided the services to the individuals enrolling in MPD. A series of questions were
asked by the student pharmacists and answers were recorded. Out of 1,547 individuals
showing up for the open enrollment clinic, only 586 of the individuals were provided
with MTM. Per Carr-Lopez (2014), inclusion criteria for MTM was established by the
Centers for Medicare and Medicaid (CMS) and allowed the MPD organizers to require
the participants of this study to take up to eight different medications in order to meet
18

standardized drug requirement for the provision of MTM services. Data analysis from the
2012 study revealed that “75% of MPD plan sponsors required a beneficiary to be taking
seven or eight medications to qualify for MTM” (Carr-Lopez et al., 2014, p. 1282). Out
of those 586 that were offered MTM, only 532 (91%) agreed to participate in the study.
Data was then taken and processed using various statistical analysis. Only 30% of those
who participated in the study admitted to medication nonadherence, but an interestingly
higher number (48%) asked questions about missed dosing. Forgetfulness was the most
reported factor in nonadherence, but “Cost of medication, even with the MPD
prescription drug benefit, was a barrier to adherence” (Carr-Lopez et al., 2014, p. 1281).
Laws Governing the Distribution of Medications
Between the federal government, state government and the Kansas State Board of
Pharmacy, the laws that govern how prescription medications are handled within the state
are determined. The Pure Food and Drug Act of 1906 is one of the earliest laws that
focused on the purity of drugs utilized in interstate commerce (Dusen & Spies, 2006).
This act did not address any false advertising or claims to those drugs; it focused on
curtailing interstate commerce of those drugs that were mislabeled or contaminated. In
1937, after a compounding error in Tennessee that killed over 100 people, there was a
public outcry for the federal government to intervene. In 1938, the Pure Food and Drug
Act was replaced by the Food, Drug and Cosmetic Act (Dusen & Spies, 2006). For the
first time in history the law mandated that all new drugs be approved prior to entering the
market. The companies looking for approval had to show safety and efficacy prior to
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being approved. Pharmacist began compounding medications in their pharmacies to be
used by the public.
Under the Food, Drug and Cosmetic Act (1938), these compounded medications
were considered new drugs and they had to be tested and approved by the FDA prior to
dispensing. Because these medicines that were being compounded were in fact a
combination of individual medications that had already been approved by the FDA, a
new law was enacted. In 1997, the Food and Drug Administration Modernization Act
replaced the Food, Drug and Cosmetic Act of 1938 (Dusen & Spies, 2006). The new act
would effectively eliminate the FDA’s ability to say that compounded drugs were
classified as new drugs.
In 1951, the Durham-Humphrey Amendment was established (Dusen & Spies,
2006). This act would cease dispensing medications without a prescription. Up until that
time individuals could walk in off the street, tell the clerk what they wanted and get it. In
1970, The Comprehensive Drug Abuse Prevention and Control Act was enacted (Dusen
& Spies, 2006). This act would effectively categorize controlled substances into 5
different classes: Schedule I, II, III, IV and V. Also, this act would dictate the storage,
dispensing and record keeping of controlled substances.
Also in 1970, the Poison Prevention Packaging Act was enacted (Dusen & Spies,
2006). This act would mandate child-resistant packaging for all medications. Up to that
point, poisonings from medications was “considered by pediatricians to be the leading
cause of injuries among children under 5 years of age” (Dusen & Spies, 2006, p. 27). In
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1987 came along the Prescription Drug Marketing Act. This act would combat the
problem of diverting bulk medicines onto the “gray market” (Dusen & Spies, 2006). This
act would later be rolled into the Food, Drug and Cosmetic Act (Dusen & Spies, 2006).
The Omnibus Budget Reconciliation Act of 1990 established that pharmacists had
to give each individual that picked up a prescription mandatory education on the
medication being purchased. The reason this act was initiated was to positively affect
therapeutic outcomes, thus saving the federal government money in the process (Dusen &
Spies, 2006). 1996 saw the dawning of the Health Insurance Portability and
Accountability Act. This act placed limits on individuals protected health information.
Current Laws Affecting APNs in the State of Kansas
Most state in the U.S. allow physicians to dispense medications to some extent
(Optum, 2015, para. 1). In many aspects relating to why the author pursued this project,
“Physicians perceive drug dispensing as reducing the drug cost to [their] patients,
reducing the cost of healthcare [and] improving drug adherence” (Munger, 2014, p. 40).
As per Kansas law, medications dispensed by physicians can only be reimbursed at a rate
equivalent to that of pharmacies, and also the insurance company may require prior
authorization before they will pay for the medication (Optum, 2015, para. 5).
Unfortunately, Kansas APNs do not get the same opportunities as physicians with regard
to being able to purchase, repackage and dispense or resell wholesale medications
without the supervision of a pharmacist. Figures 2 through 6, in Appendix A, show the
differentiation of state practices in reference to dispensing medications by nonpharmacist practitioners and physicians’. As these figures show, Kansas does not require
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physicians to be licensed to dispense medications. The only restriction is how they charge
for the medication.
Kansas Statutes Chapters 65 and 68 provide definitions utilized within the
statutes, regarding this topic. The following is a list of the main definitions that are
specific to this project:
“‘Dispenser’ means a practitioner or pharmacist who dispenses prescription
medication, or a physician assistant who has authority to dispense prescriptiononly drugs in accordance with subsection (b) of K.S.A. 65-28a08, and
amendments thereto” (Kansas Board of Pharmacy, 2014, p. 22).
“‘Mid-level practitioner’ means an advanced practice registered nurse issued a
license pursuant to K.S.A. 65-1131, and amendments thereto, who has authority
to prescribe drugs pursuant to a written protocol with a responsible physician
under K.S.A. 65-1130, and amendments thereto, or a physician assistant licensed
pursuant to the physician assistant 25 licensure act who has authority to prescribe
drugs pursuant to a written protocol with a responsible supervising physician
under K.S.A. 65-28a08, and amendments thereto” (Kansas Board of Pharmacy,
2014, p. 24-25).
“‘Practitioner’ means a person licensed to practice medicine and surgery, dentist,
podiatrist, veterinarian, optometrist or scientific investigator or other person
authorized by law to use a prescription-only drug in teaching or chemical analysis
or to conduct research with respect to a prescription-only drug” (Kansas Board of
Pharmacy, 2014, p.26).
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“‘Prescriber’ means a practitioner or a mid-level practitioner” (Kansas Board of
Pharmacy, 2014, p. 26).
“‘Wholesale distributor’ means any person, partnership, corporation, or business
firm licensed or registered in this state and engaging in the wholesale distribution
of prescription-only drugs” (Kansas Board of Pharmacy, 2014, Article 68-14-1, p.
118).
“‘Wholesale distribution” means distribution of prescription-only drugs to
persons other than a consumer or patient, but this term shall not include any of the
following: …, (3) the sale, purchase, or trade of a drug or an offer to sell,
purchase, or trade a drug by a charitable organization described in section
501(c)(3) of the U.S. internal revenue code of 1954 to a nonprofit affiliate of the
organization to the extent otherwise permitted by law;” (Kansas Board of
Pharmacy, 2014, Article 68-14-2, p. 119).
Argument for APNs to Distribute Wholesale Medications
By viewing the definitions above, the prediction could be made that the only
difference between the definitions of a mid-level practitioner and practitioner is the
supervision aspect for the mid-level practitioners. In rural America, many times these two
individuals do not work in the same office, town or even county. So, does the supervisory
role take on a more “supervisor on paper” type of roll? Even though some states may
have restrictions on which provider can prescribe scheduled (Drug Enforcement Agency,
controlled) medications, all can write nonscheduled medication prescriptions. All
practitioners (and mid-level practitioners) diagnose, treat and prescribe medications to
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their patients and in most cases this is done without any supervision of the mid-level
practitioners.
Following the same definitions listed in the statutes, the term “Practitioner”
included any person licensed to practice medicine and surgery. Even though APNs are
not licensed to perform surgery, they are licensed to practice medicine. The only real
piece of legislation standing in the way of APNs being able to purchase, repackage and
dispense or resell wholesale medications is the current difference in the definitions of
practitioners and mid-level practitioners. Possibly if future legislation were passed to give
APNs full practice authority, this may help to sway the influence in favor for APNs being
able to purchase, repackage and dispense or resell wholesale medications at their clinics
without pharmacy oversight.
Another area that could be debated is a section in Article1635, of the Kansas
Statute Chapter 65, that relates to the dispensing of medications by a duly licensed
practitioner in a town where there are no registered pharmacies. This article states
nothing in the Kansas Pharmacy Act will inhibit those individuals who are classified as
‘duly licensed practitioners’ from purchasing, repackaging and dispensing or reselling
medications to their patients. Following is an excerpt of that statute:
65-1635. Dispensing and administering of drugs by duly licensed practitioners,
…, (a) Nothing contained in the pharmacy act of the state of Kansas shall prohibit
any duly licensed practitioner from purchasing and keeping drugs, from
compounding prescriptions or from administering, supplying or dispensing to
such practitioner's patients such drugs as may be fit, proper and necessary.
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Except as provided in subsection (b) or (c), such drugs shall be dispensed by such
practitioner and shall comply with the Kansas food, drug and cosmetic act and be
subject to inspection as provided by law. (Kansas Board of Pharmacy, 2014, p.
40)
Subsection (b) references administering of medications only, and subsection (c) refers to
registered nurses being able to dispense medications under the supervision of a
practitioner prior to July 1, 1982.
If one could argue that APNs were “practitioners” who are licensed to practice
medicine within the state and are located in a town that does not have a registered
pharmacy, it may be possible to convince the state to change its regulations and statutes
to allow APNs the opportunity to care for their patients the same way that physicians do,
with regard to offering wholesale medications to their patients within the clinic setting.
Chapter Summary
The research definitively shows that the costs associated with medications is an
undeniable factor in medication adherence. Through this meta-analysis of the published
literature, collected from a wide range of various settings did reveal that among all
variables cost was definitely a determining factor in medication adherence, in the
treatment of both acute and chronic illnesses.
Mackey et al. (2015) showed that approximately half those in developed countries
were nonadherent to their medication regimens (p.2). Also, of those with chronic
illnesses, the percentage of those who were nonadherent with their medications increased
to approximately 50-60% of the population (Bosworth et al., 2011, p. 2). Medication
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nonadherence reduces the optimal health and wellness of individuals, increases the
overall costs of treatment and increased both direct and indirect costs of medical
treatment. Over half of the 3.2 billion prescriptions that are filled within the United States
are not taken as prescribed (Bosworth et al., 2011, p. 2). Patient demographics, as well as
SES have a great effect on medication adherence as well. Other factors that have been
shown to affect medication adherence included financial burdens, lack of prescription
drug coverage, and high out-of-pocket costs (Mackey et al., 2015, p. 2).
There is a clear link between the cost of medications and nonadherence. In a study
by Alton et al. (2015), which showed a 77% noncompliance rate (p. 433), the two most
frequently identified reasons were inability to afford medications (62.5%) and inability to
understand medication labels (Alton et al., 2015, p. 433). Mishra et al. (2011) also
showed a definitive link between the high cost of medications and nonadherence (p. 249).
Marcum and Gellad (2012) showed cost to be the most common health-system barrier to
medication; especially in polypharmacy and those who had higher cost-sharing (p. 4).
There is a great disconnect between the current regulations in place denying
APNs the ability to dispense wholesale medications and what is best for the patient.
When APNs are not allowed the chance to dispense wholesale medications to their
patients, especially in the setting of a charitable health clinic, the ones that suffer are the
patients. With regard to this project, not allowing wholesale medications into the
charitable health clinic may delay the care provided to patients through pharmacotherapy,
causing increased illness, increased cost, and possibly other poor outcomes to include

26

death. Legislation must be changed to incorporate a safety net for those uninsured and
underinsured within the State of Kansas.
Within the confines of this project, Kansas Statute Chapter 65, Article 1648 could
be used in the meantime to help establish wholesale medications in the charitable
health/indigent clinic. The only downfall to Article 1648 is that it would require the
assistance of a pharmacist. This article gives authorization for a nurse’s or physician’s
assistant to dispense medications in the absence of the pharmacist in charge (Kansas
Board of Pharmacy, 2014). Following is an excerpt of that article:
Kansas statutes Chapter 65, Article 1648 (d) (1) The state department of health
and environment, any county, city-county or multicounty health department,
indigent health care clinic, federally qualified health center and any private notfor-profit family planning clinic, when registered by the board, may keep drugs
for the purpose of distributing drugs to patients being treated by that health
department, indigent health care clinic, federally qualified health center or family
planning clinic. Distribution and control of prescription medications in a health
department, indigent health care clinic, federally qualified health center or family
planning clinic shall be under the supervision of a pharmacist in charge. A
designated registered nurse or nurses or a licensed physician assistant approved
by the pharmacist in charge shall be in charge of distribution and control of
drugs in the health department, indigent health care clinic, federally qualified
health center or family planning clinic under the supervision of the pharmacist in
charge when a pharmacist is not on the premises. Drugs supplied to patients
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when a pharmacist is not on the premises shall be limited to the quantity
necessary to complete a course of treatment as ordered by the practitioner
supervising such treatment. (2) The board shall adopt rules and regulations
relating to specific drugs to be used, to recordkeeping and to storage of drugs by
a health department, indigent health care clinic, federally qualified health center
or family planning clinic as are necessary for proper control of drugs. (Kansas
Board of Pharmacy, 2014, p. 53)
Until the laws are changed to allow APNs the authority to dispense medications
within the clinic setting without pharmacy or physician oversight, it will take a
multidisciplinary team approach to ensure patient care is performed. This
multidisciplinary approach will help ensure that there are no delays in the treatment of
acute or chronic illnesses in the indigent population. By ensuring there is no delay in
treatment, direct and indirect costs associated with patient medication nonadherence can
effectively be reduced.
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CHAPTER III

PLAN

Introduction
From the literature review, it has been established that cost is a substantial factor
in medication adherence/nonadherence. It could be deduced that medication adherence
would increase if the cost of medications decreased (Iuga & McGuire, 2014). However,
there is some question as to how the cost of medications can be reduced when the prices
are set by a free market enterprise, where profitability is the bottom line. The answer lies
within offering medications at wholesale cost.
As shown in Table 1 of Appendix A, readers can determine that many retail
medications’ prices are marked up more than 1000%. These markups allow retail
pharmacies to pay for their facilities, salaries and incidentals; all while making profit.
Mattingly (2012) wrote a Chain Pharmacy Industry Profile which he stated that “the
average cost for retail pharmacy operations is $11.34 for each prescription [filled]. This
means that in order for a pharmacy to earn income beyond the cost of doing business, it
must have an average reimbursement that is greater than the cost of the drug plus $11.34”
(para. 10).
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In a charitable health clinic, profits are not the driving force, so providing
wholesale medications at cost passes the savings onto the patients. To help control the
cost, the federal government set up a federal upper limit with regard to medications
purchased through Medicaid. Some states have incorporated a maximum allowable cost
(MAC) that pharmacies cannot go above; if the pharmacy pays more for the medication
than the MAC, they have to take the loss associated with the sale of that medication
(Mattingly, 2012, para. 9)
The information gained from this meta-analysis will be utilized to enlighten the
state legislators, as well as the Kansas State Board of Pharmacy and the Kansas State
Board of Nursing, on not only the problem, but also a solution that will involve changing
the current legislation to allow APNs to purchase, repackage and dispense or resell
wholesale medications at cost in CHCs across the State. Currently, most of the state
legislators are campaigning for the upcoming primary’s that will take place in August,
2016. Some of the local legislators have voiced interest in hearing more about the
research and proposed solution after the primaries are finished (L. Hibbard, personal
communication, July, 2016), (L. Jenkins, personal communication, July, 2016).
A policy analysis was performed on the various alternatives that could be
incorporated into the CHC to see what would be the best alternative to pursue. A
Practical Guide for Policy Analysis: The Eightfold Path to More Effective Problem
Solving, written by Emeritus Professor Eugene Bardach was utilized to perform the
policy analysis. The information from this project was placed within the eight steps and
the decision to do the legislative presentation was chosen as the most viable alternative to
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initiate this project. Chapter five highlights the eight step policy analysis that was used to
analyze the alternatives that were available.
The proposal to the state legislators was simple; take out the terminology referring
to “mid-level practitioners,” incorporate APNs into the classification of practitioners, this
would allow APNs to have the same privileges afforded to the physicians with regard to
the purchasing, repackaging and dispensing or reselling of wholesale medications to their
patients. During the process of this project, a simple cost analysis was performed to see
whether or not it would be feasible to incorporate wholesale medications into the CHC in
rural, southeast Kansas. Following is a summary of that feasibility study, which will be
incorporated into the presentation to the state legislators.
Market Analysis Research
The current and projected demand for medications across the nation is enormous.
With acute and chronic illnesses come the medications to treat those illnesses.
Approximately 3.2 billion prescriptions are filled each year within the Unites States, and
approximately 50%, or 1.6 billion, of these prescriptions are not taken as prescribed
(Bosworth et al., 2011, p. 2). Common sense affirms that if someone can get the same
product for less than one tenth of the cost, they will.
The target market will be those individuals that are uninsured and fall below
200% of the current poverty level. The services will be available to all individuals that
utilize the CHC, but in order to avoid taking business away from nearby pharmacies,
individuals with insurance will be asked to utilize retail pharmacies. Exceptions will be
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made for those individuals who cannot afford the medications from a nearby pharmacy if
a delay in treatment would result in rapid deterioration of their current condition.
Currently the CHC is only open on Wednesdays from 1:00 p.m. to 6:00 p.m. The
CHC averages 25 patients per half day of operation. The current demand may seem not to
justify the initial startup cost, but being able to ensure patients have access to affordable
medications for the treatment of chronic illness will be justified through decreasing
overall costs associated with medication nonadherence across the board. Initially only
small quantities of the most commonly prescribed medications will be purchased. Then,
as demand increases, the supply will be increased as well. By starting slow, adjustments
can be made in a controlled environment instead of trying to do it when business picks
up.
Competition in the area will not be a factor. This service is not being initiated to
compete with the nearby pharmacies; it is being established as a safety net for those
individuals that cannot afford retail prices at the nearby pharmacies, or those individuals
who do not have transportation to the nearest retail pharmacies eight miles away. At the
current capacity of the CHC, nearby pharmacies should not be impacted by the initiation
of this program.
The location that was selected for this program will help this program to succeed.
The clinic is centrally located between four larger communities; individuals travel up to
60 miles to utilize the clinic. At this current time the CHC is housed within a local
church, but property has been acquired to build a clinic on in the future. Also the

32

community where the clinic is located does not have local access to a pharmacy, so this
will be an added service for the community.
Key Organizational and Technological Issues
The current organizational structure of the clinic is that it falls under the 501(c)(3)
of the cooperating church. Once the new clinic building is completed, the clinic will
apply for its own 501(c)(3). The APN provider and receptionist hold positions on the
church’s Board of Directors to represent the clinic.
The CHC is run by an all-volunteer staff. The current staff is made up of a
receptionist, an LPN as office nurse, and a nurse practitioner as primary provider. Under
the current state laws, the addition of a pharmacist to the staff is needed because current
laws within the state of Kansas do not allow for a nurse practitioner to purchase,
repackage or redistribute medications without pharmacy oversight. Recruitment for a
pharmacist and pharmacy technician to join the all-volunteer staff will be the first step in
initiating this program. If a volunteer pharmacist is not found, the next step will be
contracting either a local pharmacist or a company that offers ePharmacy oversight. The
clinic operates on donation only, so pricing on contracting pharmacy or ePharmacy
support will have to be added to the current overhead cost of running the clinic.
The clinic has an electronic medical record (EMR) system that was initially set up
for concierge medicine (subscription fee based, medical care practice model). The EMR
has a module for inventorying wholesale medications and producing labels based on the
medication information within the program. A label printer will have to be purchased
which would be a one-time expense. Afterward, labels and pill bottles will need to be
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purchased on a routine basis. Cost for the packaging and labels will be added to the price
of the medication so that the program sustains itself.
If ePharmacy services are implemented, the equipment for these services will
need to be purchased as well. Currently, the CHC has the finances available to initiate the
program, but maintaining the program may be a limiting factor. Grant funding is a way to
help sustain this program and possibly to buy the equipment needed for the program.
Financial Issues
Currently, while under the covering of the church, 10% of the donations go
towards utilities and towards the church secretary handling the finances of the clinic. The
clinic’s only operating expenses are approximately $900 per year to pay for the
provider’s part-time malpractice insurance and $60 per month for telephone and fax
service, which the provider pays. The clinic has substantial funds available in its account
to sustain the current program at its current capacity. Once wholesale medications are
incorporated, a financial audit will need to be performed so that the budget can be
adjusted accordingly for the new expenses associated with this project.
Initially, the clinic will stock some of the most frequent medications the provider
prescribes. These will include classes of medications such as antibiotics,
antihypertensives, antiemetics, muscle relaxers, anti-inflammatories and cholesterol
medications. The initial order will be small enough to ensure that medications will be
used before they expire and therefore will not have to be destroyed.
Looking to the future, a stand-alone clinic must be built. The land has already
been purchased and donated to the clinic so when the funds become available, the clinic
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will be built in stages. One area that will be crucial for the development and continued
support of this program is a small room that can be devoted to storing, repackaging and
dispensing or reselling the wholesale medication storage roo Depending if grant funding
comes in, or not, this project could take a few months to a few years to complete.
Chapter Summary
Throughout this chapter different areas were addressed. First, the plan for
presenting this project to attempt to get legislation changed were discussed. Also, items
from the feasibility study were discussed including market analysis research, key
organizational and technological issues, and financial issues. As far as being a feasible
undertaking, the answer lies in the cost of the pharmacist support. If the pharmacist
comes on as a volunteer, the program is highly feasible, but as the price for this service
increases, the feasibility of this program decreases.
Reasons why retail pharmacies charge more than wholesale drug prices were
discussed, and it was determined that the average cost to operate a retail pharmacy was
$11.34 per prescription filled (Mattingly, 2012). Table 1 in the Appendix A shows that
many of the most commonly prescribed prescriptions can be had for pennies on the dollar
at wholesale prices, and when $11.34 is added on to each one, price markups near 4,0005,000%. Whereas profitability is necessary in the retail pharmaceutical industry, this
program is about affordability and will be offered to the indigent population, by a
nonprofit organization. There may be a slight markup for packaging, but it will not be the
$11.34 per prescription charged by the retail pharmacies.
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CHAPTER IV

LEGISLATIVE PRESENTATION

Introduction
As part of this project, a legislative presentation was scheduled. It was imperative
that this project be placed in motion so that hopefully legislation change will come.
Information gathered in the review of literature was used to validate the argument that
cost was a definitive factor in medication adherence in all populations around the world.
Building on that, current state laws were reviewed to show APN’s do not have the
authority to repackage wholesale medications. Various alternatives were discussed at this
presentation, but implementing legislation change was the focus.
Legislative Selection
Congresswoman Lynn Jenkins was chosen to be the main guest at this
presentation. Congresswoman Jenkins has a long history of supporting rural healthcare.
Also, Congresswoman Jenkins is a member of the United States House of
Representatives and represents the State of Kansas at the national level. Involving
Congresswoman Jenkins in this presentation meant that she would gain direct knowledge
of the problems highlighted in this project and be able to convey that knowledge to a
national, congressional audience. Other state-level senators and representatives were also
36

invited to the presentation, but due to business or personal conflicts could not attend. A
copy of the letter sent to Congresswoman Jenkins has been included in the Appendix A;
Figure 7.
Presentation Layout
The presentation was laid out in a format that would easily be followed. First a
review of the literature was highlighted to show that cost was a large barrier to
medication adherence in multiple populations. Information highlighted in this portion of
the presentation included deaths attributed each year to medication nonadherence, direct
and indirect costs associated with medication nonadherence, and the percent of the
population that was nonadherent in regards to taking their medications.
Next, the presentation focused on the significance of the problem. Theis (2013)
was quoted during the presentation to show that 1.2 billion people around the world were
living in extreme poverty. With medication cost being the focus of this project, showing
the high number of people living in poverty adds merit to the idea of incorporating
wholesale medications into the charitable healthcare setting.
Various ways in which people can be nonadherent with their medications were
discussed next. When people cannot afford their medications, they may ignore medical
advice regarding dosages. The following are examples of how individuals may be
nonadherent with their medication regimens: 1) if they are scheduled to take one pill
daily they might take it every other day instead, 2) if a medication is supposed to be taken
three times daily, they may only take it twice a day, and 3) they may only take the
medication when they identify symptoms caused by not taking the medication, then the
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discontinue the medication when the symptoms resolve. Any variation to the written
instruction from the provider is classified as being nonadherent with the medication.
After describing the problem and showing the significance of the problem, the
focus shifted to the purpose of this project. The purpose of this project was to propose
legislative change to allow NPs to purchase, repackage and dispense or resell wholesale
medications. The specific legislation to be changed is focused on definitions used to
differentiate between practitioners and mid-level practitioners. Kansas statutes chapters
65 and 68 defined practitioner as “a person licensed to practice medicine and surgery,
dentist, podiatrist, veterinarian, optometrist or scientific investigator or other person
authorized by law to use a prescription-only drug in teaching or chemical analysis or to
conduct research with respect to a prescription-only drug” (Kansas Board of Pharmacy,
2014, p.26). The proposed legislative change would drop the definition of mid-level
practitioner and change the wording to the definition of practitioner as follows: a person
licensed to practice medicine and/or surgery, with or without a collaborating agreement
as determined by state law. If this proposed change to drop the definition of mid-level
practitioner and change the definition of practitioner, APNs would achieve authority
under K.S.A. 65-1635 to purchase, repackage and dispense or resell wholesale
medications.
To validate the cost savings of providing wholesale medications in a charitable
health clinic setting a table was presented comparing costs of medications with regard to
retail and wholesale pricing. Medications that were commonly prescribed in the
charitable health clinic were depicted in this table. This table showed that retail prices
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were more than 1000% of wholesale prices in most instances. The slide presentation for
this legislation change review has been included in the Appendix A; Table 3.
The Presentation
On October 3, 2016, at 10:30 AM, a delegation from Kansas’s second
Congressional District, to include the U.S. Representative from Kansas, Congresswoman
Lynn Jenkins, met at VVCHC in Altoona, Kansas. Formal introductions were made of
persons in attendance. As mentioned before Congresswoman Lynn Jenkins was in
attendance with delegates from her office, including William Roe, District Director, and
Stephanie Lightle, District Representative. Chief executive officers from two local
hospitals were in attendance as well: Dennis Shelby, CEO of Wilson Medical Center in
Neodesha, Kansas and Nancy McKenzie, CEO of Greenwood County Hospital in Eureka,
Kansas. Dr. Jennifer Harris Ph.D., APRN represented Pittsburg State University, as the
advisor to the author’s DNP scholarly project. Along with these distinguished guests
were representatives from three local area newspapers and an area TV news station.
The presentation garnered support from Congresswoman Jenkins and her
delegates, who were in favor of elevating this proposal to legislative change further up in
the state government. William Roe stated that he would attempt to connect the author to
Kansas lawmakers prior to the next legislative session. Questions from the 2nd
Congressional District representatives, as well as the CEOs from the area hospitals were
fielded upon completion of the presentation. The presentation concluded with a tour of
the facility.
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Presentation Results
As a result of the presentation to 2nd Congressional District’s Congresswoman,
Lynn Jenkins, the importance of the proposed legislative change has Congressional
backing, thereby validating the proposal. If the Congresswoman had not been in a
position that supported rural health, she may have not elevated this proposal to the next
level within the state government. Due to her support of rural health care and comments
made during her visit, this legislative change proposal could have a congressional voice
at both the state and federal level. Also, when the legislative change proposal is presented
to state lawmakers, hopefully support will be garnered. The change that will be sought is
to have the current legislation changed in the future to allow APNs to be included in the
definition of practitioner, thus giving APNs the lawful ability to purchase, repackage and
dispense or resell wholesale medications within the state of Kansas.
After the presentation and questions, Congresswoman Jenkins approached the
author for professional insight. Congresswoman Lynn Jenkins had just returned from
Washington, D.C. where she proposed legislative change to the Social Security Act to be
vetted prior to being resubmitted during the next legislative session in January, 2017. The
proposed legislative exchange would include APNs and PAs as practitioners. She asked
the author if he would be willing to look at her proposed legislation and make any
additional changes as needed, prior to being resubmitted. Without foreknowledge of the
Congresswoman’s actions, the legislation changes proposed in this project could actually
come to fruition in the future.
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CHAPTER V

POLICY ANALYSIS

Introduction
Eugene Bardach is an Emeritus Professor of Public Policy at the Goldman School
of Public Policy, at the University of California Berkley. He wrote a book on how to
conduct an effective policy analysis titled: A Practical Guide for Policy Analysis: The
Eightfold Path to More Effective Problem Solving (Holquist, 2013). As stated in the title,
Professor Bardach broke down policy analysis into eight different steps. Those steps were
utilized to analyze the policies that inhibit APNs from being able to purchase, repackage,
and dispense or resell wholesale medications. Within the policy analysis, alternatives
were brainstormed and evaluated for not only plausibility but also for effectiveness,
reliability and ease of implementation. After the analysis was completed it was evident
that legislation change would incorporated into the action plan of implementing this
project into rural CHCs throughout the state.
Based on current definitions of practitioners and midlevel practitioners, APNs are
not authorized to purchase, repackage and dispense or resell wholesale medications. This
chapter was dedicated to analyzing the current definitions and policies using Professor
Bardach’s eight steps, these steps will be covered in the following sections of this
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chapter. This policy analysis made a refutable argument for changing definitions in the
current policy and that by doing so APNs will hopefully inherit the same rights as
physicians when it comes to the purchasing, repackaging and dispensing/reselling of
wholesale medications in rural CHCs.
Define the Problem
The problems associated with this project are twofold. The primary problem is
medication nonadherence related to the cost associated with purchasing retail
medications. The second problem is that APNs are unable to purchase, repackage and
dispense or resell wholesale medications to decrease the cost burden associated with the
purchasing of medications for both acute and chronic illnesses.
Assemble Some Evidence - Observations
As outlined in the review of literature, medication costs are a barrier to
medication adherence around the world. There are various reasons individuals may be
noncompliant, but per Marcum and Gellad (2012) “The most common health-system
barrier to medication adherence is cost” (p. 4). Mackey et al. (2015) showed that
approximately half of those in developed countries were nonadherent to their medication
regimens (p.2). Bosworth et al. (2011) showed that approximately 1.6 billion
prescriptions filled within the United States each year are not taken as prescribed (p. 2).
Alton et al. (2015), showed 62.5% of individuals they surveyed claimed inability to
afford medications as their reason for noncompliance (p. 433).
As far as APNs being able to purchase, repackage and dispense or resell
wholesale medications, the problem lies in the purchasing and repackaging of wholesale
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medications without pharmacy oversight. Advanced Practice Nurses are classified as
mid-level practitioners in the state statutes, therefor they are not afforded the same
opportunities as practitioners (“a person licensed to practice medicine and surgery,
dentist, podiatrist, veterinarian, optometrist or scientific investigator or other person
authorized by law to use a prescription-only drug in teaching or chemical analysis or to
conduct research with respect to a prescription-only drug” (Kansas Board of Pharmacy,
2014, p.26). If there were no differentiation between mid-level practitioners and
practitioners, this would not be an issue and there would be no need for legislative change
to incorporate wholesale medications in rural CHCs that are run by APNs.
Construct the Alternatives – Future Implications
There are many different alternatives that can be initiated, but all of the
alternatives hinge on oversight from a practitioner (physician) or a pharmacist. By
utilizing a practitioner to initiate this project it would necessitate that the practitioner
actually goes to the clinic in their off hours to repackage the medications themselves. As
previously discussed, many times the collaborating practitioners do not live in the same
locale as the CHCs, so this would take away from their personal time and some
practitioners may be unwilling to do this. Possibly searching out a practitioner that
already has this project established in their personal clinic could be an alternative as well.
If the practitioner would donate the cost of repackaging or do the repackaging themselves
for a nominal fee, it could make the process sustainable while keeping the cost of the
wholesale medications low enough that the individuals who utilize the services of the
CHC would be able to afford.
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Another alternative would be to incorporate a pharmacist into the CHC. Unless
one could be found to volunteer for this specific role, an added cost to the CHC would
result. If a pharmacist could not be found in the vicinity of the CHC then there are
telepharmacists that could be employed by the CHC, but this would also require the CHC
to find a pharmacy technician to volunteer or hire to assist with the repackaging of the
medications. In the case of the CHC listed in this project, it is run by donation only and
this option with an added expense may not be sustainable.
And finally, purchasing medications in a unit dose packing would be another
option to explore. With this option the decreased cost of purchasing medications in bulk
would be somewhat eliminated, thus increasing the cost of purchasing wholesale
medications by the CHC and patient’s alike. When cost is the primary reason for
incorporating this project into a CHC, this may not be the ideal alternative.
Select the Evaluation Criteria
Evaluation criteria for this project began with the scholarly project proposal.
During this phase the review of the literature was utilized to enlighten the project
committee of the problem that exists with the cost of retail medications and how it
increases patient’s medication nonadherence. Also, the committee was shown the cost
difference of medications as they relate to wholesale versus retail pricing. By gaining
approval from the committee to proceed with the project, the author’s opinion of this
project was validated.
The Health Belief Model (HBM) was chosen to evaluate and provide a framework
for this study and to address the factors associated with nonadherence. The HBM was
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written in an attempt to understand why people did not undergo preventative care for the
early detection of “asymptomatic disease” along with patient response to medication
adherence (Janz & Becker, 1984, p. 2). The proposed legislation change of this project
could address the perceived barrier of medication cost by the individual thus effecting the
overall outcome of the patient.
A legislative presentation was also used as a measure to evaluate the project. The
information was presented to Congresswoman Lynn Jenkins and the staff that
accompanied her to the presentation. Congresswoman Lynn Jenkins stated that this
project was a great idea and she would get the author in contact with her state senator to
further advance the proposal to change legislation regarding this project (L. Jenkins,
personal communications, October 3, 2016).
Further evaluation will be performed during the course of this scholarly project
and beyond. The project defense will be utilized to evaluate the legitimacy of this project
in writing. Advancing the proposed legislative change of including APNs into the
definition of practitioner through the state legislature will add another layer of evaluation
from a legislative perspective. Finally initiating the wholesale medications into the CHC,
regardless of which method is used in compliance with applicable law, will be the final
evaluation method used for this project.
Project the Outcomes – Health Policy/Practice Implications
During this phase of the policy analysis, each alternative will be analyzed to
address the specifics of this project. This step could possibly help eliminate alternatives
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that would not produce the desired effect. Even though it may not determine the most
effective alternative, it will narrow down the alternatives available
The primary objective for this project is to propose legislative change, to allow
APNs to purchase, repackage and dispense or resell also medications. As a means to an
end, this alternative would be the gold standard to incorporating wholesale medications in
a NP run, rural charitable health clinic. By getting the current legislation changed there
would be no barrier to incorporating this project.
The next option would be to incorporate a pharmacist on staff at the charitable
health clinic to perform the function of pharmacy oversight. This alternative could
possibly increase costs associated with running a charitable health clinic, unless the
pharmacist would volunteer their services to the clinic. Whether this would be a nearby
pharmacist or telepharmacist could affect the overall cost associated with their service.
Being that the clinic runs on donation only, this cost could inhibit the clinic from
incorporating this project into existence.
The final alternative discussed would be to find a practice that already has this
project incorporated. Again, there may be cost associated with that facility’s employee/s
repackaging the wholesale medications unless those individuals volunteered their
services to the clinic. Depending on the cost associated with this alternative, it could be a
better option than hiring a pharmacist, but again if legislation is passed to allow APNs to
purchase, repackage and dispense or resell wholesale medications there would be no
additional cost.
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Confront the Trade-Offs
When we confront the trade-offs, what we are ultimately doing is evaluating the
cost/benefit ratio. The information that was obtained through the alternative analysis is
reviewed and a summary statement is developed for each alternative. The summary
statements will consist of two to three sentences that verbalize the actual cost of the
alternative, as well as the benefit.
With the initial alternative listed above, legislation change would ultimately cost
time and effort. Educating members of the state legislation would be key when the
proposed legislative change came before them for vote. This would ensure each one knew
what was at stake. The benefit would be that APNs would have the authority to purchase,
repackage and dispense or resell wholesale medications.
The cost of the next alternative of recruiting a pharmacist would also cost time
and effort, but it could also cost a substantial financial obligation; unless one could be
found that would be willing to donate their time. The benefit of this alternative would be
having additional staff so that one individual would not be responsible for the entire
project. Another benefit would be not having to expand the time and energy to educate
members of the state legislation.
The cost involved with finding a facility where this project is incorporated would
be minimal time and effort to find someone who already has this project up and going.
There may be additional costs associated with having individuals from another facility
repackage the wholesale medications, unless someone was found who was willing to
donate their time and effort. The benefit to this alternative if someone was found who
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would donate their time and services, would be saving additional expenses by buying in
bulk instead of unit doses. Also, another benefit would be that the repackaged
medications would already be labeled thus saving the additional time and resources to do
that step.
Tell Your Story
During this phase of the policy analysis it is essential to “consider the three types
of audiences, (1) those that will spend 30 seconds reading your analysis, (2) those who
will spend three minutes, and (3) those that will spend 30 minutes” (Holquist, 2013).
These steps could also be incorporated into various private and corporate level verbal
presentations, in various settings. Within the confines of this project, the Congresswoman
who attended the presentation allowed for 45 minutes at the facility. In preparing for this
meeting 20 minutes was set aside for the actual presentation. The rest of the time was to
tour the facility, as well as answer any specific questions raised during the presentation.
Decide – Cost Limitation
During this step of the policy analysis we decide on which alternative is most
appropriate for the project. As it has been mentioned in previous times, cost is a definite
limiting factor for this project. Above, the alternatives have been laid out and due to cost
the legislation change would be the most cost-effective alternative to implementing this
project. If this legislation change does not pass a different alternative will be sought.
Which alternative would be initiated would depend on the costs associated to
implementing that alternative.
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Conclusion
Medication costs continue to be an obstacle to patient medication adherence in the
treatment of acute and chronic illnesses. “Prescription medication costs increase financial
burden, often leading individuals to engage in intentional nonadherence” (Martin,
Shreffler, Schoster, & Callahan, 2012, p. 236). It could be deduced that medication
adherence would increase if the cost of medications decreased (Iuga & McGuire, 2014).
The information gained from through this study can be used to educate state legislators,
the Kansas State Board of Pharmacy, and the Kansas State Board of Nursing in an effort
to define the problem and identify a solution that may involve changing current
legislation in an effort to allow APNs to purchase, repackage and dispense or resell
wholesale medications at cost in CHCs across the State. By offering medications at
wholesale cost, providers can determine if an increase in medication adherence is present
and supported by the reduced costs of purchasing medications. This project proposes a
legislative change that would amend the definition of practitioner would allow NPs to
purchase, repackage and dispense or resell wholesale medications.
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APPENDICES

APPENDIX

APPENDIX A
Figures and Tables

Figure 1. Number of publications on medication adherence over time (Goldberg,
DeKoven, Schabert,& Coyle, 2009)

Figure 2. Physician Dispensing Across the Country (Optum, 2015, p. 1)
Note: Light Blue – Legal Restrictions; Light Gray – Nonrestrictive; Dark Gray –
Reimbursement Restrictions; Dark Blue Very Restrictive
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Figure 3. Non Pharmacist Dispensing in the U.S. (Munger, 2014, p. 9)

Figure 4. Practitioners Qualified to Dispense (Munger, 2014, p. 10)
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Figure 5. Dispensing Practitioner Registration (Munger, 2014, p. 11)

Figure 6. Compliance with Pharmacy Regulations When Non-Pharmacist Dispensing
(Munger, 2014, p. 12)
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Figure 7. Invitation Letter to Congresswoman Lynn Jenkins
August 23, 2016
Dear Congresswoman Jenkins:
My name is Shawn Raymond and I am a Nurse Practitioner in rural southeast Kansas. I am
completing a Doctor of Nursing Practice (DNP) degree at Pittsburg State University (inaugural
class). Currently, I am working on a DNP Scholarly Project as part of the requirements for the
degree program. The project goal is to educate elected government officials with the potential for
legislative changes that would allow nurse practitioners to purchase wholesale medications, then
repackage and dispense these medications to the uninsured/underinsured populations within rural
communities across the state of Kansas.
After graduating PSU in 2013 with a Master of Science in Nursing degree and becoming certified
as a Nurse Practitioner, I petitioned and received approval from the Kansas Department of Health
and Environment to open an Indigent Healthcare Clinic. In October 2014, the Charitable Health
Clinic (free clinic) was opened in my hometown, Altoona, KS. Currently we have approximately
450 people from a 60-mile radius that utilize the services. A review of the literature shows that
cost is a major factor to medication adherence in the treatment of both acute and chronic illness
and adds approximately $100-$300 billion dollars each year in direct and indirect costs
(Bosworth et al., 2011, American Heart Journal). By being able to offer the
uninsured/underinsured medications at wholesale cost, the hope is to increase medication
adherence in these populations and be able to effectively increase the overall health and wellness
of these individuals.
The research of a wholesale supplier’s price list, as compared to retail pricing found retail
markups up to and greater than 1000%. The state of Kansas currently allows physicians to
purchase, repackage and dispense wholesale medications without pharmacy oversight. Since
Advanced Practice Nurses are often the available providers in rural communities, it would be
desirable to see legislation enacted that would allow nurse practitioners to be able to do the same
as physicians, in rural charitable health clinics for the uninsured/underinsured populations that
cannot afford the retail costs when purchasing medications.
Currently, I am working to set up meetings with other state officials. As I graduate in December
2016, it would be beneficial to visit with you more in depth about this issue if available anytime
between now and the end of September. I can travel anywhere for a meeting, but would be
honored to meet in Altoona, KS so you could view the facilities and programs that are offered to
the community through the Charitable Health Clinic.
Sincerely,

Shawn Raymond, MSN, APRN, NP-C
Verdigris Valley Charitable Health Clinic
215 E. 13th St.
Altoona, KS 66710
620-xxx-xxxx (Office - Wednesdays 1-6pm)
620-xxx-xxxx (Cell)
Email: sraymond@xxxx.org
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Table 1. Wholesale Medication Cost Analysis (Andamed.com and GoodRx.com, 2015)

Table 2. Verdigris Valley Charitable Health Clinic Logic Model
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Table 3. Legislative Presentation, October 3, 2017, VVCHC, Altoona, Kansas
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